Xylem Inc reports results for the quarter ended September 30 - Earnings Summary

What happened

Xylem Inc reported quarterly adjusted earnings of $1.44 per share, up from $1.37 a year earlier and just below the $1.45 analyst average. Revenue fell 3% to $2.20 billion, below the $2.28 billion expected. Reported EPS was $1.25 and net income was $291 million.

Confirmed

Global impact / market context

Earnings per share, which means profit divided by shares, rose but missed analyst expectations, while revenue declined and fell short of forecasts. That gap suggests sales weakened, which can pressure future profit and makes the stock's path depend on whether demand recovers.

Analyst inference

Analysts still rate the shares a buy on average, and the median price target of $141.00 sits about 23.2% above the last close of $108.24. Yet earnings estimates were cut slightly, showing caution even as most analysts stay positive on the stock.

Analyst inference

What to watch

1. The company reported quarterly revenue down 3% at $2.20 billion, missing the $2.28 billion analysts expected. Watch whether sales weakness continues, since falling revenue can reduce profit even when costs are controlled. Confirmed
2. In the last 30 days, three analysts negatively revised earnings estimates, and the mean estimate fell about 0.4% over three months. These cuts signal analysts expect somewhat lower profit than before. Confirmed
3. The median 12-month price target of $141.00 implies a 23.2% gain from $108.24. That target depends on revenue stabilizing; if sales keep declining, analysts may lower targets and investor expectations. Analyst inference

Evidence

• Original source link unavailable